Featured Research

from universities, journals, and other organizations

Blood pressure control: Now or later?

Date:
January 9, 2012
Source:
Springer
Summary:
Confronted with a high blood pressure value in a diabetic patient, most doctors would treat aggressively with medications. According to new research, however, delaying drug treatment for up to a year is unlikely to be harmful. The delay allows doctors and their patients to focus on lifestyle changes. The level of harm depends on the duration of the delays in blood pressure control, with significant complications occurring after 10 years of non-treatment.

Confronted with a high blood pressure value in a diabetic patient, most doctors would treat aggressively with medications. According to new research, however, delaying drug treatment for up to a year is unlikely to be harmful. The delay allows doctors and their patients to focus on lifestyle changes such as salt restriction, weight management, and exercise. According to Neda Laiteerapong and colleagues from the University of Chicago in the US, the level of harm depends on the duration of the delays in blood pressure control, with significant complications occurring after ten years of non-treatment.

Their work appears online in the Journal of General Internal Medicine, published by Springer.

Blood pressure management is integral to diabetes treatment. However, in patients with diabetes, delays in controlling blood pressure are not uncommon. Two main reasons stand out: poor access to health care for some patients and inertia by doctors and patients in those who do have access. Among those who are prescribed blood pressure drugs, at least 20 percent of patients with diabetes do not stick to their treatment. To date, the implications of these delays on patients' health have not been quantified.

Laiteerapong and team looked into the expected magnitude of harm of different delays in controlling blood pressure in patients with diabetes, using a theoretical, simulation model with a hypothetical population of adults aged 50-59 years with newly diagnosed type 2 diabetes. Compared to a lifetime of controlled blood pressure, a lifetime of uncontrolled blood pressure increased complications by 1,855 events per 10,000 patients and decreased quality-adjusted life expectancy by nearly a year (332 days). A one-year delay in controlling systolic blood pressure led to a relatively small increase in the number of complications, and a small effect on quality-adjusted life expectancy (2 days). However, multiple years of delay, especially above 10 years, led to significant declines in health outcomes. Among complications, rates of stroke and myocardial infarction increased to the greatest extent, due to delays in controlling blood pressure.

The authors conclude: "Among middle-aged adults with diabetes, the harms of a one-year delay in managing blood pressure may be small. Health care providers may wish to focus on diabetes management alone in the first year after diagnosis, to help patients establish effective self-management and lifestyle modification. However, after the first year, it is clear that achieving and maintaining tight blood pressure control among US middle-aged adults with diabetes has the potential to generate substantial population-level health benefits."


Story Source:

The above story is based on materials provided by Springer. Note: Materials may be edited for content and length.


Journal Reference:

  1. Neda Laiteerapong, Priya M. John, David O. Meltzer, Elbert S. Huang. Impact of Delaying Blood Pressure Control in Patients with Type 2 Diabetes: Results of a Decision Analysis. Journal of General Internal Medicine, 2012; DOI: 10.1007/s11606-011-1951-y

Cite This Page:

Springer. "Blood pressure control: Now or later?." ScienceDaily. ScienceDaily, 9 January 2012. <www.sciencedaily.com/releases/2012/01/120109132600.htm>.
Springer. (2012, January 9). Blood pressure control: Now or later?. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2012/01/120109132600.htm
Springer. "Blood pressure control: Now or later?." ScienceDaily. www.sciencedaily.com/releases/2012/01/120109132600.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins